304 related articles for article (PubMed ID: 23825189)
1. USP18 inhibits NF-κB and NFAT activation during Th17 differentiation by deubiquitinating the TAK1-TAB1 complex.
Liu X; Li H; Zhong B; Blonska M; Gorjestani S; Yan M; Tian Q; Zhang DE; Lin X; Dong C
J Exp Med; 2013 Jul; 210(8):1575-90. PubMed ID: 23825189
[TBL] [Abstract][Full Text] [Related]
2. Dual-specificity phosphatase 14 (DUSP14/MKP6) negatively regulates TCR signaling by inhibiting TAB1 activation.
Yang CY; Li JP; Chiu LL; Lan JL; Chen DY; Chuang HC; Huang CY; Tan TH
J Immunol; 2014 Feb; 192(4):1547-57. PubMed ID: 24403530
[TBL] [Abstract][Full Text] [Related]
3. USP18 negatively regulates NF-κB signaling by targeting TAK1 and NEMO for deubiquitination through distinct mechanisms.
Yang Z; Xian H; Hu J; Tian S; Qin Y; Wang RF; Cui J
Sci Rep; 2015 Aug; 5():12738. PubMed ID: 26240016
[TBL] [Abstract][Full Text] [Related]
4. Ubiquitin-specific peptidase 18 negatively regulates and inhibits lipopolysaccharide-induced sepsis by targeting transforming growth factor-β-activated kinase 1 activity.
Hu B; Ge C; Zhu C
Int Immunol; 2021 Aug; 33(9):461-468. PubMed ID: 34423815
[TBL] [Abstract][Full Text] [Related]
5. USP19 Inhibits TNF-α- and IL-1β-Triggered NF-κB Activation by Deubiquitinating TAK1.
Lei CQ; Wu X; Zhong X; Jiang L; Zhong B; Shu HB
J Immunol; 2019 Jul; 203(1):259-268. PubMed ID: 31127032
[TBL] [Abstract][Full Text] [Related]
6. Kinase-independent feedback of the TAK1/TAB1 complex on BCL10 turnover and NF-κB activation.
Moreno-García ME; Sommer K; Rincon-Arano H; Brault M; Ninomiya-Tsuji J; Matesic LE; Rawlings DJ
Mol Cell Biol; 2013 Mar; 33(6):1149-63. PubMed ID: 23297344
[TBL] [Abstract][Full Text] [Related]
7. T cell receptor/CARMA1/NF-κB signaling controls T-helper (Th) 17 differentiation.
Molinero LL; Cubre A; Mora-Solano C; Wang Y; Alegre ML
Proc Natl Acad Sci U S A; 2012 Nov; 109(45):18529-34. PubMed ID: 23091043
[TBL] [Abstract][Full Text] [Related]
8. USP4 targets TAK1 to downregulate TNFα-induced NF-κB activation.
Fan YH; Yu Y; Mao RF; Tan XJ; Xu GF; Zhang H; Lu XB; Fu SB; Yang J
Cell Death Differ; 2011 Oct; 18(10):1547-60. PubMed ID: 21331078
[TBL] [Abstract][Full Text] [Related]
9. Phosphoinositide-dependent kinase-1 inhibits TRAF6 ubiquitination by interrupting the formation of TAK1-TAB2 complex in TLR4 signaling.
Moon G; Kim J; Min Y; Wi SM; Shim JH; Chun E; Lee KY
Cell Signal; 2015 Dec; 27(12):2524-33. PubMed ID: 26432169
[TBL] [Abstract][Full Text] [Related]
10. TAB4 stimulates TAK1-TAB1 phosphorylation and binds polyubiquitin to direct signaling to NF-kappaB.
Prickett TD; Ninomiya-Tsuji J; Broglie P; Muratore-Schroeder TL; Shabanowitz J; Hunt DF; Brautigan DL
J Biol Chem; 2008 Jul; 283(28):19245-54. PubMed ID: 18456659
[TBL] [Abstract][Full Text] [Related]
11. USP18 recruits USP20 to promote innate antiviral response through deubiquitinating STING/MITA.
Zhang M; Zhang MX; Zhang Q; Zhu GF; Yuan L; Zhang DE; Zhu Q; Yao J; Shu HB; Zhong B
Cell Res; 2016 Dec; 26(12):1302-1319. PubMed ID: 27801882
[TBL] [Abstract][Full Text] [Related]
12. USP18 protects against hepatic steatosis and insulin resistance through its deubiquitinating activity.
An S; Zhao LP; Shen LJ; Wang S; Zhang K; Qi Y; Zheng J; Zhang XJ; Zhu XY; Bao R; Yang L; Lu YX; She ZG; Tang YD
Hepatology; 2017 Dec; 66(6):1866-1884. PubMed ID: 28718215
[TBL] [Abstract][Full Text] [Related]
13. Interaction between TAK1-TAB1-TAB2 and RCAN1-calcineurin defines a signalling nodal control point.
Liu Q; Busby JC; Molkentin JD
Nat Cell Biol; 2009 Feb; 11(2):154-61. PubMed ID: 19136967
[TBL] [Abstract][Full Text] [Related]
14. TAK1, but not TAB1 or TAB2, plays an essential role in multiple signaling pathways in vivo.
Shim JH; Xiao C; Paschal AE; Bailey ST; Rao P; Hayden MS; Lee KY; Bussey C; Steckel M; Tanaka N; Yamada G; Akira S; Matsumoto K; Ghosh S
Genes Dev; 2005 Nov; 19(22):2668-81. PubMed ID: 16260493
[TBL] [Abstract][Full Text] [Related]
15. O-GlcNAcylation of TAB1 modulates TAK1-mediated cytokine release.
Pathak S; Borodkin VS; Albarbarawi O; Campbell DG; Ibrahim A; van Aalten DM
EMBO J; 2012 Mar; 31(6):1394-404. PubMed ID: 22307082
[TBL] [Abstract][Full Text] [Related]
16. SLAM-SAP signaling promotes differentiation of IL-17-producing T cells and progression of experimental autoimmune encephalomyelitis.
Huang YH; Tsai K; Ma C; Vallance BA; Priatel JJ; Tan R
J Immunol; 2014 Dec; 193(12):5841-53. PubMed ID: 25362182
[TBL] [Abstract][Full Text] [Related]
17. Sulforaphane protects from T cell-mediated autoimmune disease by inhibition of IL-23 and IL-12 in dendritic cells.
Geisel J; Brück J; Glocova I; Dengler K; Sinnberg T; Rothfuss O; Walter M; Schulze-Osthoff K; Röcken M; Ghoreschi K
J Immunol; 2014 Apr; 192(8):3530-9. PubMed ID: 24639357
[TBL] [Abstract][Full Text] [Related]
18. MAPK phosphatase 7 regulates T cell differentiation via inhibiting ERK-mediated IL-2 expression.
Zhang Y; Nallaparaju KC; Liu X; Jiao H; Reynolds JM; Wang ZX; Dong C
J Immunol; 2015 Apr; 194(7):3088-95. PubMed ID: 25716993
[TBL] [Abstract][Full Text] [Related]
19. TRAF6 and TAK1 Contribute to SAMHD1-Mediated Negative Regulation of NF-κB Signaling.
Espada CE; St Gelais C; Bonifati S; Maksimova VV; Cahill MP; Kim SH; Wu L
J Virol; 2021 Jan; 95(3):. PubMed ID: 33177202
[TBL] [Abstract][Full Text] [Related]
20. IL-7/IL-7 Receptor Signaling Differentially Affects Effector CD4+ T Cell Subsets Involved in Experimental Autoimmune Encephalomyelitis.
Arbelaez CA; Glatigny S; Duhen R; Eberl G; Oukka M; Bettelli E
J Immunol; 2015 Sep; 195(5):1974-83. PubMed ID: 26223651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
